NEW YORK, June 30, 2017 -- According to a new market research report “Global Auto-Injectors Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insight by Product (Prefilled, Fillable), by Manufacturing Design (Standardized, Customized), by Therapeutic Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others)” published by P&S Market Research, the global auto-injectors market is expected to grow at a CAGR of 18.6% during 2017 - 2023.
As per the findings of the research, the prefilled auto-injectors is the larger product category in the global auto-injectors market, primarily due to increasing availability of user friendly prefilled auto-injectors in disposable form. Based on manufacturing design, standardized auto-injector was the larger contributor to the global auto-injectors market in comparison to customized auto-injector in 2016.
Browse Report Description with Detailed TOC on Auto-Injectors Market: https://www.psmarketresearch.com/market-analysis/auto-injectors-market
Geographically, North America has been the largest market for auto-injectors, with the U.S. being the larger contributor to the regional market, compared to Canada. Increasing cases with diabetes and anaphylaxis, rising geriatric population, and increasing production of biologics are some of the factors that have been driving the growth of the North American auto-injectors market. North America is expected to contribute over 67.0% to the global auto-injectors market by 2023. The U.K. has been the largest contributor to the European auto-injectors market, followed by Germany and France.
Globally, the pharmaceutical industry is observing a shift from administration of injections in clinician settings to home care setting. The medical device manufacturers are also shifting their focus towards the development of user friendly and patient compliant devices. The point-of-care medication administration is increasing due to improving medical services at the bed side. The auto-injectors have emerged as an impact of this change in the medical industry. Auto-injectors meet the demand of physicians and patients for easy and effective drug administration methods. They also help to reduce medication error and increase safety and convenience. The popularity of auto-injector devices is increasing due to reduced treatment cost and facilitating patients in self-administering their medication, thus leading to the growth of the global auto-injectors market.
Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/auto-injectors-market/report-sample
Key companies in the auto-injectors market are collaborating to offer advanced auto-injectors. In March 2017, Mylan N.V. entered in a global settlement and license agreement with Genentech Inc and Roche Holding AG in relation to patents for Herceptin (trastuzumab), which provides Mylan N.V. with global licenses for its trastuzumab product. This is expected to help Mylan N.V. to commercialize trastuzumab globally, except in Japan, Brazil and Mexico.
Some of the key players operating in the global auto-injectors market include Mylan N.V., Antares Pharma Inc., Becton, Dickinson & Co., Eli Lilly and Company, Pfizer, Inc., Bayer AG, Novartis International AG, Bristol-Myer Squibb, Novartis AG, Amgen Inc. and Biogen Inc.
Browse Other Related Research:
Nerve Repair and Regeneration Market
Point-of-Care Ultrasound Device Market
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact: Kundan Kumar Manager – Client Partner 347, 5th Ave. #1402 New York City, NY - 10016 Toll-Free: +1-888-778-7886 (USA/Canada) Email: [email protected] Web: https://www.psmarketresearch.com


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Anta Sports Expands Global Footprint With Strategic Puma Stake
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



